Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen for Barrett's Esophagus
NCT02089386Phase 1Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Jul 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tamoxifen in Barrett's esophagus, sponsored by Washington University School of Medicine. Primary endpoint: Extent of Barrett's involvement and changes in histology at 12 weeks. Started Jul 2014; status: terminated.
02
Drugs
tamoxifen
03
Conditions
Barrett's esophagus
Beyond the preview
Go deeper on NCT02089386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02089386.